Crisi et al. used MR PWI in a cohort of 59 patients with GBM to identify 14 quantitative radiomic features that were used to build a DL model to classify MGMT promoter methylation status into three groups: unmethylated (<10% methylated), intermediate-methylated (10–30% methylated), and methylated (>29% methylated). Here, MGMT is linked to glioblastoma.